TANG CAPITAL MANAGEMENT LLC Diversified Active

CIK: 0001232621 · Show all filings

Period: Q1 2017 (← Previous) (Next →)

Filing Date: May 15, 2017

Total Value ($000): $276,666 (100.0% shares, 0.0% debt)

Holdings (5)

HRTX HERON THERAPEUTICS INC 46.9%

Value ($000) $129,824 Shares 8,654,914 Est. Cost $13.92 Unrealized -0.5%

— LA JOLLA PHARMACEUTICAL CO 37.1%

Value ($000) $102,697 Shares 3,440,419 Est. Cost $16.25 Unrealized —

— IGNYTA INC 12.3%

Value ($000) $34,166 Shares 3,972,800 Est. Cost $5.43 Unrealized —

BMRN BIOMARIN PHARMACEUTICAL INC 2.9%

Value ($000) $7,919 Shares 90,215 Est. Cost $62.32 Unrealized +42.8%

— CYCLACEL PHARMACEUTICALS INC 0.7%

Value ($000) $2,060 Shares 559,900 Est. Cost $5.17 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
HRTX	HERON THERAPEUTICS INC	8,654,914	$129,824	46.9%	$13.92	-0.5%	COM	427746102
—	LA JOLLA PHARMACEUTICAL CO	3,440,419	$102,697	37.1%	$16.25	—	COM	503459604
—	IGNYTA INC	3,972,800	$34,166	12.3%	$5.43	—	COM	451731103
BMRN	BIOMARIN PHARMACEUTICAL INC	90,215	$7,919	2.9%	$62.32	+42.8%	COM	09061G101
—	CYCLACEL PHARMACEUTICALS INC	559,900	$2,060	0.7%	$5.17	—	COM	23254L405